Desoxybromoscaline
| Clinical data | |
|---|---|
| Other names | DBR; 4-Bromomescaline; 3,5-Dimethoxy-4-bromophenethylamine; 4-Bromo-3,5-dimethoxyphenethylamine; 4-Br-3,5-DMPEA; 3,4,5-MBM |
| Routes of administration | Unknown |
| Drug class | Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H14BrNO2 |
| Molar mass | 260.131 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Desoxybromoscaline (DBR), also known as 4-bromo-3,5-dimethoxyphenethylamine (4-Br-3,5-DMPEA) or as 4-bromomescaline, is a serotonin receptor modulator of the phenethylamine and desoxyscaline families related to the psychedelic drug mescaline. It is the analogue of mescaline in which the methoxy group at the 4 position has been replaced with a bromine atom. The drug is also the phenethylamine (α-desmethyl) analogue of 4-Br-3,5-DMA and a positional isomer of 2C-B (4-Br-2,5-DMPEA).
Category:
- Drugs not assigned an ATC code